文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Profound consequences of hidradenitis suppurativa: a review.

作者信息

Matusiak Ł

机构信息

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Chałubińskiego 1,, 50-368, Wrocław, Poland.

出版信息

Br J Dermatol. 2020 Dec;183(6):e171-e177. doi: 10.1111/bjd.16603. Epub 2018 May 9.


DOI:10.1111/bjd.16603
PMID:29744872
Abstract

Hidradenitis suppurativa (HS) influences patients' lives in many ways. The most troublesome symptom of HS is chronic pain, of mild-to-moderate intensity, which is reported by almost all patients. With reference to psychosocial evaluation, HS appears to be a highly debilitating disease. The major factors influencing patients' well-being are disease severity, the number of flares or affected skin areas, and the lesion location. The mean Dermatology Life Quality Index scores of 8·3-12·7 points obtained among patients with HS are typical for severe dermatoses, which have a large impact on patients' quality of life (QoL). HS not only affects skin-related QoL issues, but also has a profound impact on general QoL measures - it causes substantial deterioration of both physical and mental health. Considering the impaired QoL due to HS and HS-associated, nonpsychiatric comorbidities, it is not surprising that patients with HS experience psychological disturbances. In both observational and registry studies, depression and anxiety were significantly related to HS. The prevalences were estimated as 1·6-42·9% and 0·8-3·9%, respectively. HS was also linked to feelings of loneliness and stigmatization. Moreover, these patients have a significantly increased suicide risk (hazard ratio 2·42). HS, with its frequent involvement of the genital area, causes a pronounced impairment of sex life (66·7% of patients with HS reported sexual difficulties). Finally, HS causes significant financial burden, not only through the costs of healthcare, but also due to a substantial impact on patients' professional careers. This is a reason for absenteeism from work for approximately half of patients, and a relatively high unemployment rate.

摘要

相似文献

[1]
Profound consequences of hidradenitis suppurativa: a review.

Br J Dermatol. 2020-12

[2]
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.

Int J Environ Res Public Health. 2021-6-22

[3]
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.

Dermatol Ther (Heidelb). 2024-1

[4]
Psychosocial burden of Hidradenitis Suppurativa patients' partners.

J Eur Acad Dermatol Venereol. 2020-8

[5]
Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa.

Dermatol Ther. 2021-5

[6]
To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?

Br J Dermatol. 2018-10-16

[7]
Alexithymia, Psychological Distress, and Social Impairment in Patients with Hidradenitis Suppurativa.

Dermatology. 2021

[8]
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.

J Eur Acad Dermatol Venereol. 2022-9

[9]
Assessing the psychological burden of patients with hidradenitis suppurativa.

Eur J Dermatol. 2019-6-1

[10]
Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice.

J Eur Acad Dermatol Venereol. 2020-6

引用本文的文献

[1]
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.

Dermatol Ther (Heidelb). 2025-7-13

[2]
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.

Dermatol Ther (Heidelb). 2025-6-29

[3]
Serum C-Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Cross-Sectional Cohort Study.

Int J Dermatol. 2025-9

[4]
Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials.

Dermatol Ther (Heidelb). 2025-5-15

[5]
Evaluation of the Psychosocial Burden of Hidradenitis Suppurativa and Relevant Factors: A Prospective Single-Center Study.

Sisli Etfal Hastan Tip Bul. 2025-3-18

[6]
Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data.

Dermatol Ther (Heidelb). 2025-5

[7]
Impaired Molecular Mechanisms Contributing to Chronic Pain in Patients with Hidradenitis Suppurativa: Exploring Potential Biomarkers and Therapeutic Targets.

Int J Mol Sci. 2025-1-25

[8]
Increased risk of migraine among patients with hidradenitis suppurativa: A US multi-center cohort study.

Biomed J. 2024-11-19

[9]
Epidermal stem cells: skin surveillance and clinical perspective.

J Transl Med. 2024-8-22

[10]
Beyond caregiving: Navigating life with a developmentally disabled daughter with a severe case of Hidradenitis Suppurativa.

Skin Health Dis. 2024-6-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索